Analgesia for Endometrial Scratching
NCT02863614 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2018-05-08
Summary
The aim of this study is to evaluate whether Ibuprofen alone or combined with lorazepam reduce the pain associated with endometrial scratching/injury.
Conditions
- Subfertility
- Infertility
Interventions
- DRUG
-
Ibuprofen 600 mg
- DRUG
-
Lorazepam 1 mg
- DRUG
Sponsors & Collaborators
-
University of Sao Paulo
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2017-05-31
- Completion
- 2017-05-31
More Related Trials
-
Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis
NCT02158845 ·Status: COMPLETED ·Phase: PHASE4
-
Resveratrol for Pain Due to Endometriosis
NCT02475564 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial
NCT02180256 ·Status: TERMINATED ·Phase: NA
-
The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation
NCT06316219 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain
NCT01767090 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea
NCT06317064 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Endometrial Scratching on Patients With Endometriosis
NCT05360875 ·Status: UNKNOWN ·Phase: NA
-
Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice
NCT01303614 ·Status: UNKNOWN ·Phase: PHASE4
-
Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea
NCT03126747 ·Status: COMPLETED
-
Subcutaneous Progesterone Supplementation in Patients With Endometriosis
NCT02793908 ·Status: UNKNOWN ·Phase: PHASE3
-
Letrozole in the Treatment of Severe and Recurrent Endometriosis
NCT00240942 ·Status: COMPLETED ·Phase: PHASE2
-
Adenomyosis and Ulipristal Acetate
NCT02587000 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese Postmenopausal Women
NCT00826436 ·Status: COMPLETED
-
Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis
NCT02480647 ·Status: COMPLETED ·Phase: PHASE4
-
Pain Associated With Endometriosis
NCT00758953 ·Status: COMPLETED ·Phase: PHASE2
-
IUD and Norethindrone Acetate for Treatment of Endometriosis
NCT04948489 ·Status: WITHDRAWN ·Phase: PHASE2
-
Endometrial Effects of Lipiodol
NCT03542331 ·Status: UNKNOWN ·Phase: PHASE3
-
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis
NCT01116440 ·Status: TERMINATED ·Phase: PHASE2
-
Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women
NCT00110487 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis
NCT00675779 ·Status: UNKNOWN ·Phase: NA
-
The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery
NCT04554693 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy of Diclofenac on Pain During Endometrial Sampling
NCT01762306 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
NCT02894151 ·Status: COMPLETED ·Phase: PHASE2
-
A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
NCT00244452 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
NCT03325868 ·Status: WITHDRAWN ·Phase: PHASE4